Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BM.4.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BM.4.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BM.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BM.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.20EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.20ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.20ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.20EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.20EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.20ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AZ.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AZ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AZ.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AZ.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AZ.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AZ.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AZ.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AZ.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.97EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.97EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.97ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.97ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.97EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.97EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.97ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.97ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.18EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.36.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.18ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.36.18ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.36.18EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.36.18EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.36.18ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.32EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.32ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.32ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.32EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.32EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.32ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.59EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.59EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.59ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.59ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.59EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.59EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used